Published in Transplantation on December 15, 2003
Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes (2010) 2.07
The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation (2008) 1.83
Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant (2009) 1.29
Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms. Diabetes (2013) 1.17
Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev (2008) 1.12
{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab (2010) 1.04
Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99
HLA sensitization in islet transplantation. Clin Transpl (2006) 0.97
Autologous pancreatic islet transplantation in human bone marrow. Diabetes (2013) 0.97
Islet grafting and imaging in a bioengineered intramuscular space. Transplantation (2009) 0.93
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2). Diabetologia (2012) 0.93
Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Albany NY) (2009) 0.92
Influence of microenvironment on engraftment of transplanted β-cells. Ups J Med Sci (2011) 0.91
Early metabolic markers of islet allograft dysfunction. Transplantation (2009) 0.91
Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients. J Clin Endocrinol Metab (2008) 0.90
Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes? Diabetes Care (2015) 0.88
The use of biomaterials in islet transplantation. Curr Diab Rep (2011) 0.88
Anti-proinflammatory effects of sirolimus on human islet preparations. Transplantation (2008) 0.87
Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine. Transpl Int (2010) 0.87
Intraportal islet oxygenation. J Diabetes Sci Technol (2014) 0.86
Utility of co-transplanting mesenchymal stem cells in islet transplantation. World J Gastroenterol (2011) 0.83
Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy. Transplant Proc (2011) 0.82
Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy. Cell Transplant (2011) 0.81
Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels. Am J Physiol Endocrinol Metab (2011) 0.81
Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. Islets (2009) 0.79
Striated muscle as implantation site for transplanted pancreatic islets. J Transplant (2011) 0.79
Extracellular Matrix and Growth Factors Improve the Efficacy of Intramuscular Islet Transplantation. PLoS One (2015) 0.78
Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets. Clin Exp Immunol (2012) 0.77
Imaging of transplanted islets by positron emission tomography, magnetic resonance imaging, and ultrasonography. Islets (2013) 0.76
Assessing the effect of immunosuppression on engraftment of pancreatic islets. Transplantation (2013) 0.76
Coculturing Human Islets with Proangiogenic Support Cells to Improve Islet Revascularization at the Subcutaneous Transplantation Site. Tissue Eng Part A (2016) 0.75
Islet cell transplant: Update on current clinical trials. Curr Transplant Rep (2016) 0.75
Oxygenation of the Intraportally Transplanted Pancreatic Islet. J Diabetes Res (2016) 0.75
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell (2006) 5.28
Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med (2003) 4.12
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest (2012) 3.65
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest (2013) 2.38
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med (2002) 2.29
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes (2004) 2.22
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation (2004) 2.13
Liver transplantation with donation after cardiac death donors: a comprehensive update. J Surg Res (2012) 2.10
Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant (2005) 2.04
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol (2005) 2.00
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther (2008) 1.90
Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting. Diabetes (2013) 1.90
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87
SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem (2003) 1.82
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A (2007) 1.81
Geographic disparities in deceased donor liver transplantation within a single UNOS region. Liver Transpl (2007) 1.81
Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab (2006) 1.76
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood (2006) 1.75
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72
Geographic inequity in access to livers for transplantation. Transplantation (2011) 1.71
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
The natural history of hepatitis C virus in pediatric liver transplant recipients. Liver Transpl (2006) 1.61
Combined lung and liver transplantation: the United States experience. Transplantation (2005) 1.58
Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell (2003) 1.57
Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes (2003) 1.55
B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med (2007) 1.53
Long-term follow-up of portopulmonary hypertension patients after liver transplantation. Liver Transpl (2014) 1.53
Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res (2010) 1.51
Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol (2006) 1.51
Neonatal hemochromatosis: radiographical and histological signs. Liver Transpl (2005) 1.50
GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation (2009) 1.48
Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol (2007) 1.47
Decreased use of iliac extensions and reduced graft junctions with software-assisted centerline measurements in selection of endograft components for endovascular aneurysm repair. J Vasc Surg (2004) 1.46
Analysis of recent pediatric orthotopic liver transplantation outcomes indicates that allograft type is no longer a predictor of survivals. Liver Transpl (2008) 1.46
Geographic differences in access to transplantation in the United States. Transplantation (2003) 1.42
Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model. Radiology (2012) 1.41
Discovery of a human peptide sequence signaling islet neogenesis. Endocr Pract (2008) 1.38
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant (2005) 1.36
Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology (2004) 1.35
Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol (2004) 1.34
B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol (2006) 1.34
Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg (2007) 1.34
Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem (2003) 1.32
Some considerations for management of choledochal cysts. Am J Surg (2004) 1.32
Islet vasculature as a regulator of endocrine pancreas function. World J Surg (2007) 1.31
Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res (2009) 1.30
Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev (2003) 1.28
{beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes (2005) 1.28
Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes (2003) 1.27
Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant (2007) 1.26
Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes (2003) 1.25
Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer (2004) 1.22
General surgery as a career: a contemporary review of factors central to medical student specialty choice. J Am Coll Surg (2004) 1.22
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. Angew Chem Int Ed Engl (2013) 1.21
Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant (2004) 1.20
Laparoscopic colon resection early in the learning curve: what is the appropriate setting? Ann Surg (2006) 1.19
Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife (2013) 1.19
Split-liver transplantation: results of statewide usage of the right trisegmental graft. Am J Transplant (2005) 1.19
Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin Cancer Res (2003) 1.18
BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice. PLoS Genet (2010) 1.18
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes (2010) 1.18
Research resource: the pdx1 cistrome of pancreatic islets. Mol Endocrinol (2012) 1.17
PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas (2008) 1.17
Glucose regulation of insulin gene transcription and pre-mRNA processing in human islets. Diabetes (2007) 1.17
Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes (2005) 1.16
TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol (2014) 1.15
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer. Mol Ther (2011) 1.15
Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes (2013) 1.15
Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15